Triumphalis is the newest prohormone on the market. The first unsponsored logs are indicating that this hormone is like no other, as users report no loss of libido, and an increase in appetite – along with steady muscle and strength gains and an increase in muscle hardness Triumphalis is versatile enough to be used for cutting, bulking or recomping, with an anabolic:androgenic ratio similar to superdrol.
Prohormones Database Description
Methyldiazirinol was first synthesized by researchers at Lederle Laboratories, a subsidiary of American Cyanamid. Their results were reported in 1965. They patented the invention in 1966. Lederle/American Cyanamid also synthesized some 2a-cyano-substituted compounds similar to Cynostane. Methyldiazirinol was one of many steroids listed in Julius Vida’s Androgens and Anabolic Agents. In a section detailing “Compounds displaying decreased androgenic activity coupled with increased anabolic activity”, the 3,3-azo steroid is listed alongside steroids such as oxandrolone (anavar), methenolone (primobolan), stanozolol (winstrol) and norbolethone (one version of “the Clear”). According to the Lederle Laboratories researchers, the Methyldiazirinol has an oral anabolic:androgenic ratio of 300:20 when compared to methyl testosterone, giving it a “Q factor” of 15. This provides anabolic to androgenic effects similar to the recently-banned methasterone (superdrol), which was reported to have an anabolic:androgenic ratio of 400:20. Methyldiazirinol was never commercialised, though they continued to explore the possibilities of the diazirine group in other (non-steroidal) molecules.
|Active ingredients||3,3-azo-17a-methyl-5a- androstan-17b-ol 150 mg|
|Brand||Iron Legion Supplements|
|Legal status UK||Legal|
|Legal status USA||Legal|